RN Collins (Series 3) No.8: No Standard of Care, No Medical Status, Full Liability: The Facilitator Malpractice Question Oregon’s Framework Raises

RN Collins (Series 3) No.8

RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.

This is the 8th in the series

Contact RN Collins: https://www.linkedin.com/in/rn-collins/

July 2026

No Standard of Care, No Medical Status, Full Liability: The Facilitator Malpractice Question Oregon’s Framework Raises

The disclaimer/duty tension at the center of Oregon’s psilocybin framework, the SSRI screening gap, and the documentation and insurance questions that may matter before the first case is filed

RN Collins, M.S., JD Candidate

https://www.linkedin.com/in/rn-collins

I. Introduction

Oregon’s Measure 109 created a new professional category and, in the same set of rules, appears to have disclaimed its clinical character. The licensed psilocybin facilitator is required to complete approved training, pass a competency examination, maintain licensure through annual continuing education, and supervise clients through multi-hour altered-state experiences. The facilitator must screen for contraindications, recognize medical emergencies, maintain professional boundaries, and apply a standard of care that reasonable facilitators in similar circumstances would use. The facilitator is also told, in statute, in rule, and in the required client-facing documents, that psilocybin services are not medical treatment.

This tension does not appear to be simply a drafting inconsistency. It may reflect a central design choice in the Oregon framework, one that plausibly was intended to avoid triggering healthcare facility regulation, insurance mandates, and licensure requirements that could have made the framework difficult to implement. One effect of this design choice, whether intended or not, is a professional category with duties that read as clinical in character but without a settled body of clinical doctrine to define them. Regulatory data suggest that roughly a third of licensed service centers had closed as of early 2026, that SSRI use may be common among clients without corresponding screening guidance, and that the client base appears to be growing, developments that may make a facilitator negligence filing more likely over time, though the timing and even the eventual occurrence of such a case cannot be predicted with confidence. If and when such a case is filed, a court may need to address questions the framework does not appear to resolve on its face.

This article attempts to identify those questions and, where the material allows, to suggest possible answers, while acknowledging that much of this analysis remains untested by any court. Section II maps the regulatory framework and the apparent disclaimer/duty tension. Section III explores what a standard-of-care analysis might look like by analogy to related fields. Section IV identifies three liability categories that the OAR rules appear to create. Section V discusses vicarious liability and the independent-contractor question, along with a post-closure duty question raised by recent service center closures. Section VI discusses documentation and insurance considerations that may be relevant to service centers and facilitators operating under current rules, and concludes with recommendations addressed to Oregon regulators and the legislature.

II. The Regulatory Framework: Disclaimer and Duty

A. The Disclaimer

The non-medical character of Oregon psilocybin services is stated at multiple levels of the framework. ORS § 475A.305 provides that “a psilocybin service center is not a health care facility subject to ORS chapter 441.” OAR 333-333-1010(72) prohibits use of the term “therapy” or any variant suggesting that psilocybin services constitute medical or clinical treatment. The informed consent document required by OAR 333-333-5040 must state that psilocybin services are not health care services and that a facilitator is not a health care professional.

The disclaimer appears to serve a specific regulatory function: it places the service center outside Oregon’s health care facility regulatory structure and places the facilitator outside the professional licensure structure that governs physicians, psychologists, and licensed counselors. As a practical matter, this means OHA’s psilocybin program, rather than the Oregon Medical Board or the Board of Licensed Social Workers, functions as the primary regulatory authority, and that the facilitator’s conduct is governed by OAR 333-333 rather than by an existing clinical professional practice standard.

B. The Duty

The same OAR rules that disclaim clinical status also impose obligations that read, at least in substance, as clinically oriented. OAR 333-333-5120(1) imposes a duty of care: the facilitator “has a duty to put clients’ interest above their own and to use a standard of care that other reasonable facilitators would use under similar circumstances.” OAR 333-333-5050 requires screening for psychosis history, family history of psychosis, active suicidal ideation with intent or plan, and medications including lithium, without, on its face, providing guidance on what a facilitator is to do with the information obtained.

OAR 333-333-5120(4) requires the facilitator to recognize medical emergencies and contact emergency services immediately. OAR 333-333-5120(7) and (10) prohibit sexual contact and other boundary violations. OAR 333-333-5120(9) prohibits the facilitator from leaving a client unattended who is not in a stable condition. OAR 333-333-4700 requires the service center to have emergency response protocols and to ensure that facilitators are trained to implement them.

The gap between the disclaimer and the duties may be where a malpractice claim would ultimately need to be litigated. The disclaimer suggests this is not medical care and that the facilitator is not a clinician. The duties suggest otherwise: screen for psychiatric contraindications, recognize emergencies, maintain a standard of care, put the client’s interest above one’s own. A court resolving a facilitator negligence claim would likely need to encounter this apparent gap and would need some analytical framework for addressing it. That framework is the subject of Section III.

III. The Standard-of-Care Problem

A. Analogous Relationships

Three analogous professional relationships may offer a useful, though not conclusive, doctrinal framework for analyzing what a facilitator’s standard of care could look like. The mental health counselor relationship appears closest in scope of duty: both involve professional-client relationships in which the professional provides services during a vulnerable psychological state, has a duty to screen for contraindications, and must respond to psychiatric emergencies. The massage therapist relationship may be closest in the boundary-violation context: both involve relationships with bodily contact between professional and client in a setting of physical and psychological vulnerability. The research protocol administrator arguably provides the most developed adverse-event and emergency-response model available: clinical research protocols for psychedelic administration have specific contraindication screening requirements, adverse-event reporting obligations, and emergency-response procedures that may represent the best currently available professional consensus on what competent psilocybin session management could look like, though these protocols were not designed with the Oregon facilitator model specifically in mind.

A court might draw on some combination of these three analogies depending on which liability category is at issue, though which analogy would predominate in practice is not something that can be stated with confidence absent litigated precedent. A boundary-violation claim would likely engage the massage therapist and mental health counselor doctrine most directly. A contraindication-screening-failure claim would likely engage the research protocol and mental health counselor doctrine. An emergency-response-failure claim might engage the research protocol doctrine most directly. This suggests that a standard-of-care analysis may be more usefully organized by liability category than by analogy alone, a framing developed further in Section IV.

B. The SSRI Non-Exclusion Gap

Perhaps the most significant unaddressed standard-of-care question in the Oregon framework concerns SSRI use. Oregon does not prohibit clients using selective serotonin reuptake inhibitors from accessing psilocybin services. The OAR mandatory screening form does not include an SSRI inquiry. Psychedelic Alpha’s Q1 2025 data estimates that up to 80% of Oregon service center clients may be using SSRIs at the time of their session, though this figure is itself an estimate and may not generalize precisely across all service centers or time periods.

SSRIs and psilocybin appear to have a known pharmacological interaction: SSRIs may reduce the subjective effects of psilocybin by downregulating 5-HT2A receptor density, potentially producing an attenuated or unpredictable session. Of possibly greater concern from a liability standpoint, abrupt SSRI discontinuation, which some clients may undertake before a psilocybin session without clinical guidance, can produce a discontinuation syndrome with psychiatric symptoms including anxiety, irritability, and depressive rebound that may be difficult to distinguish from psilocybin-related adverse effects during a session.

Whether a reasonable facilitator, trained in accordance with OAR 333-333-3050 and 3060’s curriculum requirements, would be expected to inquire about SSRI use beyond the OHA-mandated form is a question that would likely require expert testimony to resolve in any litigated case, and it is not possible to say with certainty how such testimony would come out. Given that SSRI use may affect a substantial share of clients, this does not appear to be a marginal liability category. It may plausibly be among the more common unaddressed contraindication exposures in the Oregon market, though the actual incidence of adverse outcomes tied specifically to SSRI interactions is not well documented in available data.

This gap may be one area where Oregon regulators could consider action. OHA might consider adding an explicit SSRI inquiry to the mandatory screening form, and could consider issuing guidance on documenting such inquiries and addressing SSRI interaction risk within the informed consent process. Such a step would not necessarily require new legislation; it could plausibly be implemented through the existing rulemaking process addressing OAR 333-333-5120(1)’s standard-of-care obligation as applied to a known pharmacological interaction that appears to affect a substantial proportion of the client population.

IV. Specific Liability Categories

A. Contraindication Screening Failure

The screening liability category could arise where a facilitator conducts an administration session for a client with a contraindicated condition that the screening process did not identify. OAR 333-333-5050’s mandatory client information form requires inquiry about psychosis history, family psychosis history, active suicidal ideation with intent or plan, and lithium use. The form does not require inquiry about SSRIs, other psychiatric medications, cardiac medications, or other conditions with known psilocybin interaction profiles.

A facilitator who follows the OAR-mandated form to the letter and proceeds with a session that produces an adverse outcome from a condition the form did not cover may be in a legally uncertain position. The form may provide evidence of compliance with a minimum regulatory standard, but it does not necessarily define the full standard of care that a court would apply. Expert testimony about what facilitator training programs teach regarding contraindications, and about whether a reasonable facilitator would have taken additional screening steps, would likely be needed to determine whether the OAR minimum is also treated as the legal minimum, and this is a question the framework leaves open.

B. Session Management Failure

Session management liability could arise where a facilitator fails to appropriately respond to events during the administration session. The relevant OAR obligations include OAR 333-333-5120(4) (contact emergency services immediately for medical emergencies), OAR 333-333-5120(9) (do not leave a client unattended if not in a stable condition), and OAR 333-333-4700 (emergency response protocols). A facilitator who fails to contact emergency services when a client exhibits signs of a medical emergency, or who leaves a client in an unstable condition, would appear to have violated specific OAR rules, which could make the regulatory violation relevant to a negligence analysis, though how directly a court would treat regulatory violation as establishing the negligence standard is not settled.

The session management liability category may be an area where contemporaneous documentation carries particular weight. OAR 333-333-4820 requires records retention, and SB 303 requires outcome data submission to OHA. Both appear to create records of what happened during a session. Facilitators who document their decision-making contemporaneously, including the basis for decisions not to contact emergency services, would likely be in a stronger position to defend their conduct. Facilitators who do not document contemporaneously may be left relying largely on recollection against a client’s account, which could be a difficult position in litigation.

C. Boundary Violation

The boundary-violation liability category may be the most straightforward of the three in light of existing professional liability case law in adjacent fields. OAR 333-333-5120(7) prohibits sexual contact between facilitator and client, and OAR 333-333-5120(10) prohibits romantic or sexual relationships for one year following the session. These prohibitions appear to track the professional boundary rules that govern mental health counselors and massage therapists in Oregon, an area with a comparatively well-developed body of case law.

The particular vulnerability of the psilocybin facilitation context, extended altered-state sessions in which clients may be psychologically open and often physically vulnerable, could make boundary violations both more likely to occur than in some conventional professional relationships and potentially more damaging when they do occur, though this comparative claim is difficult to verify empirically given limited data. Ordinary negligence and breach-of-fiduciary-duty theory, applied to the OAR 333-333-5120(7) and (10) boundary prohibitions discussed above, appear to be the more doctrinally sound basis for a civil claim here. Oregon does not appear to have a single dedicated civil-liability statute specifically addressing sexual misconduct by licensed professionals generally, and this application to psilocybin facilitators specifically has not been tested in any reported case.

V. Vicarious Liability and Post-Closure Duty

A. The Independent Contractor Question

Many Oregon service centers appear to use independent contractor agreements rather than employment agreements with their facilitators. The independent contractor structure carries an apparent advantage for service centers: if the facilitator is not an employee, the service center might argue it is not vicariously liable for facilitator negligence under respondeat superior. This argument may face at least two significant obstacles, though how a court would ultimately weigh them is not certain.

First, Oregon courts apply a multi-factor test for determining whether a worker is an employee or independent contractor, which includes the degree of control exercised by the service center over the manner and means of the facilitator’s work. Service centers that specify session protocols, require facilitators to use OHA-mandated forms, establish emergency response procedures, mandate training standards, and maintain oversight through post-session documentation requirements could be seen as exercising a degree of control that may be sufficient to defeat independent contractor status under Oregon’s common law employment test, though this would depend on the specific facts of each arrangement.

Second, Restatement (Third) of Agency § 7.08 provides that a principal may be liable for the tortious conduct of a non-employee agent when the principal retains control over the physical conduct of the agent in the performance of the task. A service center that requires facilitators to follow its protocols, use its forms, and operate within its facility could plausibly be characterized as a principal with retained physical control under § 7.08, regardless of the label used in the service agreement, though this remains an inference rather than a settled legal conclusion. This exposure may be worth addressing at the drafting stage of independent contractor agreements, and it is an area where clearer guidance from regulators or the legislature could reduce uncertainty for service centers structuring their staffing arrangements.

B. Post-Closure Liability

A distinctive liability scenario appears to have emerged from Oregon market data: service center closures. Approximately one-third of Oregon’s licensed service centers had closed as of early 2026, according to available tracking data. Clients who were in active therapeutic relationships, mid-integration after an administration session, may have been left without ongoing facilitator support when their service center closed, though the scope of this problem across the market is not fully documented.

Whether a service center’s closure triggers any duty to clients in active therapeutic relationships, or whether an integration-session duty under Restatement (Second) of Torts § 324A (voluntary undertaking to render services for another’s protection) might survive the service center’s dissolution, does not appear to have been litigated, and this analysis cannot be stated with certainty absent a decided case. A service center that closes without notifying clients in active integration periods, without providing referral resources, and without ensuring documentation access could conceivably face a § 324A claim for abandonment of a voluntary undertaking, though whether such a claim would succeed is an open question. This may be an area where Oregon regulators could consider requiring, as a condition of licensure or closure, that service centers adopt minimum client-notification, referral, and documentation-preservation practices before ceasing operations.

VI. Documentation and Insurance

A. SB 303 and the Discoverable Record

Oregon’s SB 303 (2023, effective 2025) requires service centers to collect and submit to OHA client outcome data, including numbers of clients served, adverse reactions, dosing averages, and denial reasons. This appears to create an OHA-maintained record that could be sought in discovery in a facilitator negligence case, though whether and to what extent such records would be discoverable, and under what evidentiary rules, has not been tested in any reported proceeding. This raises a question about whether service centers’ internal documentation practices are consistent with what gets submitted to OHA under SB 303, and whether any inconsistency between the two records could itself become a point of litigation exposure.

Beyond the SB 303 layer, documentation practices generally might be evaluated against OAR 333-333-4820’s records retention requirements. Documents that are missing, incomplete, or internally inconsistent could undermine a service center’s defense and may raise independent negligence questions related to recordkeeping.

B. The ORS § 475A.338 Dual-License Question

ORS § 475A.338(1)(b) and (2)(b) (as enacted by Or. Laws 2025, ch. 147, § 4, operative Jan. 1, 2026), titled “Ability of health care provider, behavioral health care provider, to conduct certain sessions; protection from discipline,” addresses the intersection between licensed healthcare providers and the psilocybin services framework. Subsection (1)(b) permits a person licensed by an enumerated healthcare board (counseling and therapy, naturopathic medicine, psychology, medicine, nursing, social work, or pharmacy) who also holds an ORS 475A.325 facilitator license to conduct preparation and integration sessions concurrently with health care practice, and to conduct administration sessions only where the person is not simultaneously providing health care services. Subsection (2)(b) is the operative protection-from-discipline provision: it shields the dual-licensed provider from disciplinary action by their healthcare board specifically on the condition that they “not provide health care services while providing psilocybin services.” That statutory condition supplies the textual hook for the dual-standard question this section raises, but it does not resolve the harder factual question of what counts as “providing health care services” during a session that blends clinical judgment with facilitation. Whether a mental health counselor who is also a licensed facilitator would face both the facilitator standard and the counselor standard for conduct that arguably crosses that line does not appear to have been adjudicated, and this question may remain open until a case squarely presents it.

C. Insurance Considerations

Professional liability insurance for psilocybin facilitators appears to exist in the market but does not seem to be standardized. The three OAR liability categories discussed above, contraindication screening failure, session management failure, and boundary violation, may be a useful reference point for evaluating what a policy covers. General liability policies typically cover bodily injury and property damage; they generally do not cover professional negligence claims. Errors and omissions policies are reportedly emerging in this space, but their exclusions may not align neatly with these specific categories. Whether an E&O policy covers (1) failure to screen for a contraindicated condition not included on the OHA-mandated form, (2) failure to contact emergency services under OAR 333-333-5120(4), and (3) sexual boundary violations under OAR 333-333-5120(7) may be worth examining closely, since a gap in any of the three could leave a service center effectively self-insured against what may be among the more likely claim categories.

Recommendations

The following considerations are offered as possible directions for Oregon regulators and the legislature, rather than as instructions to any individual practitioner or service center.

1. Oregon Health Authority could consider amending the OAR 333-333-5050 mandatory screening form to include an explicit SSRI inquiry, given data suggesting that a substantial share of clients may be using SSRIs and that no current screening guidance addresses this interaction.
2. Oregon Health Authority may wish to issue clarifying guidance on how facilitators should document contraindication screening and emergency-response decision-making, given that OAR 333-333-4820’s retention requirements do not appear to specify a documentation standard beyond retention itself.
3. The Oregon Legislature could consider clarifying, through amendment or interpretive guidance, whether and to what extent SB 303 outcome-data submissions are discoverable in civil proceedings, since this question appears unresolved and may affect how service centers approach compliance.
4. Oregon Health Authority may wish to consider adopting minimum requirements, perhaps as a condition of licensure, for client notification, referral, and documentation preservation when a service center closes or ceases operations, in light of the apparent closure rate among licensed centers.
5. The Oregon Legislature or Oregon Health Authority could consider clarifying the dual-license question under ORS § 475A.338, specifically whether a licensed healthcare provider who is also a psilocybin facilitator is held to one standard, both standards, or some blended standard for conduct performed while providing psilocybin services.
6. State insurance regulators may wish to examine whether errors and omissions policies marketed to psilocybin service centers reliably cover the three liability categories identified in this article, and could consider requiring clearer disclosure of coverage gaps to licensees.

None of these recommendations resolves the underlying disclaimer/duty tension identified in Section II, which may ultimately require either legislative clarification or judicial resolution in a litigated case. The Oregon framework’s central design choice, clinical-grade duties paired with a mandatory non-medical disclaimer, appears likely to remain a live legal question until such a case arises, and this article does not purport to predict when or how that will occur.

Endnotes

1. ORS § 475A.305 (psilocybin service center not a health care facility); OAR 333-333-1010(72) (prohibiting term “therapy”); OAR 333-333-5130 (prohibiting diagnosis or treatment); OAR 333-333-5040 (informed consent document requirements, including statement that services are not health care); OAR 333-333-5120(1) (standard of care obligation; duty to put client’s interest above facilitator’s own), https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=323163.
2. OAR 333-333-5050 (client information form: required screening for psychosis history, family psychosis, suicidal ideation with intent or plan, lithium use); OAR 333-333-5120(4) (emergency services contact); OAR 333-333-5120(7) (prohibition on sexual contact); OAR 333-333-5120(9) (no unattended client in unstable condition); OAR 333-333-5120(10) (one-year post-session romantic/sexual relationship prohibition); OAR 333-333-4700 (emergency response protocols); OAR 333-333-3050 and 3060 (facilitator training curriculum requirements), https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=323139.
3. Psychedelic Alpha, Oregon Psilocybin Services Tracker (Q1 2025) (estimating up to 80% of clients may be using SSRIs at time of session; reporting Q1 2025 adverse event rate of 6 per 1,509 clients), https://psychedelicalpha.com/data/the-oregon-psilocybin-services-tracker; Or. S.B. 303 (2023) (client outcome data reporting to OHA, effective 2025), https://olis.oregonlegislature.gov/liz/2023R1/Measures/Overview/SB303; OAR 333-333-4820 (records retention requirements).
4. Restatement (Third) of Agency § 7.08 (2006) (principal liability for tortious conduct of non-employee agent with retained physical control), https://www.ali.org/publications/show/agency/; Restatement (Second) of Torts § 314A (1965) (special relations giving rise to duty to aid or protect), https://www.ali.org/publications/show/torts/; Restatement (Second) of Torts § 324A (1965) (liability to third persons for negligent performance of undertaken services); Restatement (Second) of Torts § 874 (1979) (breach of fiduciary duty), https://www.ali.org/publications/show/torts/; ORS § 475A.338(1)(b), (2)(b) (enacted by Or. Laws 2025, ch. 147, § 4 (HB 2387), operative Jan. 1, 2026) (dual-licensed provider protection from professional discipline, conditioned on not providing health care services while providing psilocybin services), https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB2387/Enrolled; ORS § 475A.450 (client confidentiality), https://www.oregonlegislature.gov/bills_laws/ors/ors475A.html.